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Background-—Coronary heart disease (CHD) represents often the underlying conditions for the development of heart failure (HF).
We aimed at exploring the burden and timing of HF complicating an acute myocardial infarction (AMI), using the total population of
AMI patients hospitalized during 2001–2009 in Norway.
Methods and Results-—A total of 86 771 patients with a first AMI during 2001–2009 and without previous HF were identified in
the “Cardiovascular Disease in Norway” project and followed until HF development, death, or December 31, 2009. In 16 219
patients (18.7%), HF was present on admission or developed during hospitalization for the incident AMI. HF occurrence varied
according to age (8.9%, 15.2%, and 25.6% among men and 10.2%, 16.8%, and 27.1% among women ages 25–54, 55–74, and 75–
85 years). Among 63 853 patients discharged alive without HF, 8058 (12.6%) were hospitalized with or died because of HF during
a median follow-up time of 3.2 years. HF incidence rates (IRs) per 1000 person-years during follow-up were 31 (95% CI, 30–32) for
men and 46 (95% CI, 44–47) for women (P<0.01). IRs of HF were highest during the first 6 months of follow-up, after which they
leveled off and remained stable until the end of follow-up.
Conclusions-—In this nation-wide cohort study, we observed that HF remains a frequent complication of the first AMI; both during
the acute phase and shortly after the discharge from the hospital. ( J Am Heart Assoc. 2016;5:e002667 doi: 10.1161/
JAHA.115.002667)
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H eart failure (HF) accounts for the majority of hospitaladmissions among people older than 65 years and
carries a poor prognosis.1 Although its etiology encompasses
various conditions, coronary heart disease (CHD),2 in partic-
ular, acute myocardial infarction (AMI),3 is among the most
frequent underlying causes.
Recent changes in diagnostic criteria and advances in
treatment have greatly influenced survival of patients suffer-
ing an AMI. This, combined with aging of the population, has
increased the number of patients living with various degrees
of myocardial damage and being at risk of developing HF.4 In
this context, HF is considered the “price to pay” for positive
changes characterizing coronary care during the last decades.
To illustrate, a Global Burden of Disease study reported that
despite reductions in AMI incidence and improved survival,
the prevalence of HF attributed to ischemic heart disease has
increased during 1990–2010.5
Incidence of HF among patients hospitalized for an AMI
varies widely among earlier studies, reaching up to 50%.6
Later studies conducted during the revascularization era7–9
also agree that HF is a common complication of AMI.10
The timing of HF occurrence in relation to the AMI
event is important because it can provide information on
the mechanisms involved and thereby help reduce the
burden of HF. The majority of studies, however, have
focused only on early-phase HF (developed during the
hospitalization for the AMI) with only a limited number of
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studies extending the follow-up period after discharge
from the first AMI.7,8
Therefore, the purpose of these analyses was to describe
the incidence of HF as a complication of the first (index)
AMI, focusing on the timing of occurrence by using a
nationwide cohort of patients hospitalized in Norway during
2001–2009.
Methods
The “Cardiovascular disease in Norway” (CVDNOR) project
(https://cvdnor.b.uib.no) is established in collaboration
between the University of Bergen and the Norwegian Knowl-
edge Centre for the Health Services.11 Information on all
hospital stays with International Classification of Disease
(ICD)-9 codes 390 to 459 or ICD-10 codes I00-I99 were
retrieved during 1994–2009 from the electronic patient
administrative systems (PAS) in all somatic hospitals in
Norway. Information includes patient’s sex, age, admission
and discharge dates, up to 20 discharge diagnoses, and
information on diagnostic/treatment procedures performed
during that hospitalization. Information on individuals who
died (either in Norway or abroad) was retrieved from the
Norwegian Cause of Death Registry.
A unique personal identification number assigned to each
Norwegian resident allowed us to trace patients for transfers
within or between hospitals and follow them after being
discharged from the hospital.
The Study Population and Endpoint
We identified all individuals ages 25 to 85 years who were
hospitalized for their first AMI (coded as I21, I22 in ICD-10)
during 2001–2009 (ie, during the previous 7 years they had
not been hospitalized with an AMI)12 and did not have
previous hospitalizations attributed to HF. They were followed
until the study endpoint, death or December 31, 2009 (end of
follow-up), whichever came first.
The study endpoint was a combination of hospitalizations
for, or deaths with, HF (I50 in ICD-10) as the underlying or
contributing cause of death.
Based on the timing of the HF occurrence in relation to the
index AMI, we distinguished between in-hospital HF (defined
as HF on admission or which developed during the hospital-
ization for the index AMI) and post-AMI discharge HF (defined
as either a hospitalization with HF or death attributed to HF as
underlying or contributing cause, after being discharged from
the index AMI hospitalization).
Continuous variables are presented as mean (SD) for
normally distributed variables or median (5th–95th percentile)
if data distribution was skewed. Categorical variables are
presented as numbers and proportions.
Logistic regression and linear regression analyses were
used to compare baseline characteristics between men and
women (Table 1) or between patients developing in-hospital
HF or post-AMI discharge HF and those who did not develop
HF during the follow-up (Table 2).
Competing-risk Cox proportional hazard regression was
used to model the effect of age group at the hospitalization
for an incident AMI on the risk of post-AMI discharge HF. Sex-
specific cumulative incidence function curves (subhazard
curves) were constructed for 3 age groups; young (25–
54 years); middle-aged (55–74 years); and elderly (75–
85 years). This approach was chosen over conventional
Kaplan-Meier survival curves to account for death; an
important competing risk for the development of post-AMI
discharge HF in this subset of patients.
The timing of post-AMI discharge HF development was
presented by plotting HF incidence rates (calculated for 6-
month time intervals) against the time from discharge from
the index AMI.
Statistical Analysis
Statistical analyses were performed using STATA software
(version 13; StataCorp LP, College Station, TX). Two-sided
tests with a 0.05 significance level were used. The informed
consent was waived because data were collected from a
national registry. The study protocol was approved by the
Regional Committee for Medical and Health Research Ethics,
Health Region West.
Results
Among 94 883 patients ages 25 to 85 years who were
hospitalized for an index AMI in Norway from 2001 through
2009, 8112 had previous hospitalizations for HF and were
therefore excluded from the analyses (Figure 1).
Compared to men, women were, on average, 6 years older
(65.9 vs 72.1 years; P<0.001) and had a higher proportion of
diabetes mellitus (DM), hypertension, chronic obstructive
pulmonary disease (COPD), and stroke. Renal failure was
more frequent among men. A higher proportion of women had
atrial fibrillation (AF) whereas ventricular fibrillation (VF)
during the index AMI hospitalization was more frequent
among men. Women had longer hospital stays, but were less
likely to receive diagnostic and revascularization procedures
compared to men. These differences in the distribution of the
baseline characteristics remained statistically significant after
adjusting for age (Table 1).
Overall, 24 277 patients (28%) developed HF either during
the hospitalization for the incident AMI or after discharge
(total HF). Age group–specific proportions of total HF were
12.2% in young, 22.4% in middle-aged, and 39.5% in elderly
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men. The corresponding age group–specific proportions of
total HF among women were 13.4%, 24.5%, and 41.5%,
respectively.
Presence of HF was associated with a significant increase
in mortality. Proportion of deaths among men with HF was
61.4% compared to 28.3% among those without HF. Such
differences were observed in each age group (20.1% vs 7.4%
among young, 47.8% vs 21.2% among middle-aged, and 81.8%
vs 62.0% among elderly men). A similar association between
presence of HF and increased mortality was observed among
women, overall (70.0% vs 39.2%) and in each age group
(23.2% vs 10.1% among young, 52.2% vs 25.2% among
middle-aged, and 80.1% vs 59.3% among elderly women).
In-Hospital HF
A total of 16 219 patients (18.7% of the study population)
presented with or developed HF during hospitalization for the
incident AMI. HF occurrence was largely influenced by age. It
varied from 8.9% among young (25–54 years), 15.2% among
middle-aged (55–74), to 25.6% among elderly (75–85 years)
men. The corresponding proportions of in-hospital HF among
women were 10.2%, 16.8%, and 27.1%, respectively. Such sex
differences in the proportion of in-hospital HF were statisti-
cally significant for all age groups (P=0.03 in young, P<0.01 in
middle-aged, and P=0.02 in elderly patients; Figure 2).
Patients with in-hospital HF were older and had a longer
hospital stay compared to those who were discharged without
HF. After adjusting for age, in-hospital HF patients had more
often DM, COPD, renal failure, atrial fibrillation (AF), and
adverse cardiac events, such as ventricular fibrillation (VF)
and atrioventricular block. They were also less likely to
undergo coronary angiography and receive myocardial revas-
cularization (percutaneous coronary intervention [PCI] or
coronary artery bypass grafting [CABG]) compared to those
without HF. No differences between groups were observed
with regard to stroke whereas hypertension was more
prevalent among patients not developing HF (Table 2).
Post-AMI Discharge HF
Of 63 853 patients discharged alive from the index AMI and
without a diagnosis of HF, 8058 (12.6%) developed HF later at
some point during a median (interquartile range) follow-up
Table 1. Baseline Characteristics of Men and Women Hospitalized for the First AMI in Norway During 2001–2009: A CVDNOR
Project
Patient Characteristics Men (n=57 475) Women (n=29 296) P Value
Age, mean (SD) 65.9 (12.5) 72.1 (11.2) <0.001
Age group, n (%)
25 to 54 y 11 518 (20.0) 2638 (9.0)
55 to 74 y 28 075 (48.9) 11 093 (37.9)
75 to 85 y 17 882 (31.1) 15 565 (53.1)
Comorbidities, n (%)
Diabetes mellitus 7366 (12.8) 4188 (14.3) 0.002
Stroke 1647 (2.9) 1403 (4.8) <0.001
Hypertension 15 362 (26.7) 9270 (31.6) <0.001
Chronic obstructive pulmonary disease 4216 (7.3) 2858 (9.8) <0.001
Chronic renal failure 1823 (3.2) 761 (2.6) <0.001
Cardiac coexisting conditions/complications, n (%)
Atrial fibrillation 6952 (12.1) 4287 (14.6) <0.001
Ventricular fibrillation 1283 (2.2) 439 (1.5) <0.001
Atrioventricular block 755 (1.3) 439 (1.5) 0.892
Length of AMI hospitalization (days), median (5th–95th percentile) 6 (3–27) 7 (5–31) <0.001
Procedures during hospitalization for the index AMI, n (%)
Coronary angiography 26 787 (46.6) 10 302 (42.7) <0.001
Percutaneous coronary intervention 18 286 (31.8) 6219 (21.2) <0.001
Coronary artery bypass grafting 3837 (6.6) 1170 (4.0) <0.001
P values are obtained from logistic regression or linear regression analyses comparing men to women and are adjusted for age.
AMI indicates acute myocardial infarction; CVDNOR, Cardiovascular Disease in Norway.
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time of 3.2 (1.2–5.7) years. In 1045 of the AMI cases (13.0%),
HF occurred within 30 days and in another 2626 (32.6%)
between 30 days and 1 year from the index AMI discharge.
The proportion of patients developing post-AMI dischargeHF
increased with age in bothmen andwomen. The sex differences
in these proportions were statistically significant only among
middle-aged patients (9.0% in men vs 9.9% in women; P=0.01),
but not among the young (3.7% in both sexes) and elderly (22.7%
in men vs 23.6% in women; P=0.13; Figure 2).
Patients with post-AMI dischargeHFwere older, had a longer
hospitalization for the index AMI hospitalization, had more
comorbidities (DM, COPD, renal failure, and AF), and were less
likely to receive coronary angiography and myocardial revas-
cularization compared to those not developing HF (Table 2).
Timing of the Post-AMI Discharge HF
Figure 3 shows sex-specific cumulative subhazard risk of
developing post-AMI discharge HF across different age
groups of the cohort of AMI patients. Among male patients
surviving their index AMI, 6% of young, 15% of middle-aged,
and 40% of elderly were subsequently hospitalized with, or
died from, HF during follow-up. The corresponding propor-
tions of post-AMI discharge HF among female patients were
7%, 16%, and 40% (Figure 3). No statistically significant sex
differences in risk of HF were observed among young
(P=0.9) and elderly (P=0.1), whereas a borderline signifi-
cance level (0.49) was observed among middle-aged
patients.
The overall incidence rates (IR) of post-AMI discharge HF
per 1000 person-years during the study period was 31 (95%
CI, 30–32) among men and 46 (95% CI, 44–47) among women
(P<0.01). Age group–specific overall incidence rates (IRs)
were 9 (95% CI, 8–10), 24 (95% CI, 22–25), and 81 (95% CI
78–84) among men and 9 (95% CI, 7–11), 26 (95% CI, 24–28),
and 81 (95% CI, 78–85) among women ages 25 to 54, 55 to
74, and 75 to 85 years, respectively. Statistically significant
sex differences in IRs were observed only among middle-aged
patients (P=0.02), but not among the young (P=0.41) or
elderly (P=0.45).
Table 2. Baseline Characteristics of Patients Hospitalized for the First AMI With or Without Heart Failure (HF) During Follow-up: A
CVDNOR Project
Patient Characteristics No HF (n=62 494) In-Hospital HF (n=16 219) Post-AMI Discharge HF (n=8058)
Age, mean (SD) 66.1 (12.5) 72.5 (10.9)* 73.7 (9.9)*
Age group, n (%)
25 to 54 y 12 399 (19.8) 1291 (8.0) 466 (5.8)
55 to 74 y 30 169 (48.3) 6143 (37.8) 2856 (35.4)
75 to 85 y 19 926 (31.9) 8785 (54.2) 4736 (59.8)
Sex (men), n (%) 42 716 (68.4) 9872 (60.9) 4887 (60.6)
Comorbidities, n (%)
Diabetes mellitus 7239 (11.6) 2870 (17.7)† 1445 (17.9)†
Stroke 2044 (3.3) 675 (4.2) 331 (4.1)
Hypertension 18 021 (28.8) 4196 (25.9)† 2415 (30.0)
Chronic obstructive pulmonary disease 4226 (6.8) 1864 (11.5)† 984 (12.2)†
Chronic renal failure 1338 (2.1) 906 (5.6)† 340 (4.2)†
Cardiac coexisting conditions/complications, n (%)
Atrial fibrillation 6038 (9.7) 3594 (22.2)† 1607 (19.9)†
Ventricular fibrillation 1070 (1.7) 538 (3.3)† 114 (1.4)
Atrioventricular blocks 743 (1.2) 309 (1.9)† 142 (1.8)‡
Length of AMI hospitalization (days), median (p5–p95) 6 (2–23) 10 (4–44)† 7 (3–31)†
Procedures during hospitalization for the index AMI, n (%)
Coronary angiography 29 186 (46.7) 5700 (35.2)† 2203 (27.3)†
Percutaneous coronary intervention 19 741 (31.6) 3393 (20.9)† 1371 (17.0)†
Coronary artery bypass grafting 3676 (5.8) 1046 (6.5)† 285 (3.6)‡
AMI indicates acute myocardial infarction; CVDNOR, Cardiovascular Disease in Norway.
*P<0.001 for comparisons between patients with in-hospital HF or post-AMI discharge HF with those without HF during the follow-up (adjusted for sex).
†
P<0.001 for comparisons between patients with in-hospital HF or post-AMI discharge HF with those without HF during the follow-up (adjusted for age and sex).
‡
P<0.01 for comparisons between patients with in-hospital HF or post-AMI discharge HF with those without HF during the follow-up (adjusted for age and sex).
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Incidence of post-AMI discharge HF was highest during
the first months and dropped at 1 year after the index
AMI. After that, IRs remained stable. Despite age differ-
ences in rates, the described time-dependent distribution
of events was very similar between younger, middle-aged,
and elderly patients among both men and women
(Figure 4).
Discussion
We observed that HF remains still a common complication
among patients hospitalized with their first AMI and follows a
time-dependent pattern with high IRs during the first months
up to 1 year post-AMI discharge, dropping and remaining
stable thereafter.
Previous knowledge on HF complicating an AMI mostly
comes from studies focusing on in-hospital HF. Among 483
incident AMI cases recruited during 1992–1996, 4% presented
with signs of HF on admission and another 39% developed HF
during MI hospitalization.13 Data from the Global Registry of
Acute Coronary Events (GRACE) revealed that that among
13 707 ACS patients hospitalized during 1999–2001, 13% had
HF on admission and another 5.6% developed HF during the
hospital stay.14 Spencer et al. found that 20.4% of 123 938
AMI patients hospitalized during 1994–2000 presented with
signs of HF whereas another 8.6% developed HF during
hospitalization.15 A more recent study including 187 803 AMI
patients hospitalized during 2007–2011 found that 12% of
patients presented with signs of HF at admission and another
4% developed HF during hospitalization.8
Similar to ours, some other studies have reported the total
proportion of patients developing HF during a hospitalization
Figure 1. Flow chart showing selection of the study population and development of heart failure in relation to the first (index) acute
myocardial infarction: a CVDNOR project. AMI indicates acute myocardial infarction; CVDNOR, Cardiovascular Disease in Norway; HF indicates
heart failure.
Figure 2. Proportion of patients with acute myocardial infarc-
tion (AMI) complicated with in-hospital (fully colored bars) and
post-AMI discharge (light-colored bars) heart failure (HF) by sex
and age group: a CVDNOR project. CVDNOR indicate Cardiovas-
cular Disease in Norway.
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for an AMI, without distinguishing between cases in whom HF
was present on admission or those who developed it during
the hospitalization. Velazquez and Pfeffer16 reported that
among 5566 patients hospitalized for an AMI during 1999–
2001, 42% were complicated with HF during AMI hospitaliza-
tion. An analysis using data from the Euro Heart Survey
reported that 26% of 9587 ACS patients hospitalized during
2000–2001 presented with HF at admission or developed it
during the hospital stay.17 Data from the FAST-MI registry in
France showed that 32% of 3059 AMI patients enrolled in the
study during 2005 presented or developed HF during the AMI
hospitalization.7 Our results are in line with recent register-
based studies including similar patients to ours8,18 with
regard to development of in-hospital HF.
We could identify only 2 studies extending their investiga-
tion beyond hospitalization for the index AMI and reporting on
post-AMI discharge HF.4,9 One study included 896 AMI
patients hospitalized in the UK in 1998 and reported a
proportion of in-hospital and post-AMI discharge HF of 46%
and 33%, respectively.9 The other study included 7733
patients over 65 years hospitalized for their first AMI between
1994 and 2000 in Canada, of whom 37% were diagnosed with
HF during the index AMI and, among the remaining, another
64% developed HF within 1 year of discharge.
Differences in findings from various studies are largely
influenced by differences in patient populations. That includes
selection of only incident13 versus mixed AMI cases,7,8,15
exclusion13–15 or not9,19 of patients with a history of HF, and
differences in the definition of the study endpoint (mild, severe,
or any type of HF). Results of these studies taken together
indicate a redistribution of HF occurrence in time. The
proportion of cases presenting with signs of HF at the time of
admission for an AMI is increasing (from 4% during 1992–
199613 to 12%–13% during 2001–20118,14), whereas the
proportion developing HF during AMI hospitalization has greatly
decreased from 39%13 to 4% to 8%.8,14 HF being present on
admission for an AMI is an indicator of coronary heart disease
severity in terms of disease anatomical extension and myocar-
dial involvement.20,21 Such an increase may reflect the decline
in the proportion of AMI patients dying outside hospitals that
Norway,12 like other countries22–24 are experiencing. Thus, it is
feasible that, currently, more-severe cases reach the hospital
alive and are at greater risk of presenting signs of HF on
admission than in former time periods. On the other hand, the
reduction in the proportion of AMI patients developing HF
during AMI hospitalization can, to a great extent, be explained
by better access to revascularization (including early revascu-
larization), leading to myocardial salvage.
Another important factor to be considered is changes in
characteristics of the AMI population. Since the troponin
inclusion in diagnostic algorithm of AMI, patients are older
and presenting more often with non-ST elevation myocardial
infarction (NSTEMI). Besides being a strong predictor of HF in
and of itself,25 older age is associated with more comorbidi-
ties and influences treatment decisions.
Other factors influencing treatment approaches are AMI
subtype and anatomical characteristics of atherosclerotic
Figure 4. Sex- and age group–specific incidence rates of post-
AMI (acute myocardial infarction) discharge heart failure (HF)
among patients hospitalized for the first acute myocardial infarc-
tion: a CVDNOR project. CVDNOR indicate Cardiovascular Disease
in Norway.
Figure 3. Sex-specific cumulative incidence of post-AMI (acute
myocardial infarction) discharge heart failure (HF) by age group: a
CVDNOR project. CVDNOR indicate Cardiovascular Disease in
Norway.
DOI: 10.1161/JAHA.115.002667 Journal of the American Heart Association 6















plaques and time from symptom onset to hospitalization.
Such factors might help explain, in part, the undertreatment
observed among older AMI patients during their hospital
stay26–28 and upon discharge.29 Regardless of the cause, lack
of revascularization leads to more patients leaving the
hospital with myocardial damage and therefore being at high
risk of developing HF.
Strength and Limitations
This is the first study describing the burden and timing of
HF in a nation-wide, unselected cohort of patients hospi-
talized with their first AMI. Our study population was
selected after introduction of troponin in AMI diagnostic
algorithms,30 reducing the effect of the well-known diag-
nostic shift in AMI patient characteristics. Through record
linkages with hospital discharge diagnoses and the Cause
of Death Registry, we were able to conduct a complete
follow-up of the cohort. Exclusion of prevalent AMI cases
minimized the effect of a mixture of incident and prevalent
cases. We also excluded patients previously hospitalized
with HF, maximizing the probability that the diagnosed HF
occurring during follow-up was a complication of the index
AMI.
Our study carries also some limitations. We were unable to
distinguish between AMI patients presenting with signs of HF
on admission and those developing it during the hospital stay.
Therefore, the 2 groups are combined under the in-hospital HF
category in the analyses. Data from general practitioners or
hospital outpatient visits were not available; hence, our
analyses were restricted to more-severe cases requiring
hospitalization or resulting in death. Furthermore, the ICD-10
codes obtained from hospital PAS do not distinguish between
ST-elevation (STEMI) and NSTEMI. However, previous studies
did not find any differences in the occurrence of HF between
STEMI and NSTEMI.8,14
Another limitation of this study is the lack of information
on evidence-based therapy (including use of thrombolysis)
applied to AMI patients during hospitalization and at dis-
charge.
Although information on invasive myocardial revasculariza-
tion procedures (PCI and CABG) was available, we did not
know the chronology of the events among cases developing
in-hospital HF (ie, HF present on admission render the patient
not a good candidate for PCI or lack of PCI in a timely manner
led to HF) and therefore could not speculate on the direction
of the association. PAS do not provide information on whether
there were medical conditions, severity of disease, contraindi-
cations, or other reasons (eg, lack of proper communication
between medical staff and patients or patient refusal to
undergo such procedure) that led to the patient not receiving
such treatment.
Although the data in the CVDNOR project have been
previously investigated and found to be of good quality,31,32
we have not specifically checked the quality of coding for
HF and that is a limitation of our study. A previous meta-
analysis has shown that the quality of HF coding in PAS
vary widely from study to study.33 Such variation is
dependent on several factors including the gold standard
used for comparison, the ICD version used, and the study
population. A study conducted in Sweden reported that the
quality of HF diagnosis from the discharge registers is
slightly inferior to AMI and stroke diagnoses.34 Further-
more, another study conducted in the UK showed that
hospital discharge codes underestimate the true number of
patients hospitalized with or complicated by HF.35 However,
prevalence of HF based on both ICD-9 and ICD-10 codes
among AMI patients was shown to be in agreement with
chart reviews.36
Last, our definition of incident AMI is based on the absence
of a previous AMI hospitalization for the same individual
during a retrospective search of 7 years. Therefore, there is a
small chance that some of the AMI cases defined by us as
“incident” could be recurrences.
Conclusion
HF remains a frequent complication of AMI both during the
acute phase and soon after discharge. The risk of HF can be
influenced by a combination of factors related to patient
characteristics, such as age, comorbidities, and AMI type, as
well as to underuse of early revascularization procedures,
especially among elderly patients.
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